Evidence map›Paper›PMID 39944725›Full record

ReviewJournal of tissue engineering

In vitro and ex vivo models of the oral mucosa as platforms for the validation of novel drug delivery systems.

Robyn A Macartney, Abijit Das, Atina G Imaniyyah, Annabelle Tr Fricker, Andrew M Smith, Stefano Fedele, Ipsita Roy, Hae-Won Kim, Dongjoon Lee, Jonathan C Knowles

Abstract readReview
In one paragraph

Review in Journal of tissue engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. [Oral mucosal administration].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2026
    Article
  4. Review
  5. Review
  6. Impact of NbACS omega · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Robyn A MacartneyDivision of Biomaterials and Tissue Engineering, University College London (UCL) Eastman Dental Institute, London, UK.ORCID https://orcid.org/0000-0002-2452-7478
Abijit DasInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, Republic of Korea.
Atina G ImaniyyahDivision of Biomaterials and Tissue Engineering, University College London (UCL) Eastman Dental Institute, London, UK.
Annabelle Tr FrickerSchool of Chemical, Materials & Biological Engineering, Faculty of Engineering, University of Sheffield, Sheffield, UK.
Andrew M SmithDepartment of Microbial Diseases, UCL Eastman Dental Institute, University College London, London, UK.
Stefano FedeleUCL Eastman Dental Institute, University College London, London, UK.
Ipsita RoySchool of Chemical, Materials & Biological Engineering, Faculty of Engineering, University of Sheffield, Sheffield, UK.ORCID https://orcid.org/0000-0002-9042-9913
Hae-Won KimInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, Republic of Korea.ORCID https://orcid.org/0000-0001-6400-6100
Dongjoon LeeInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, Republic of Korea.
Jonathan C KnowlesDivision of Biomaterials and Tissue Engineering, University College London (UCL) Eastman Dental Institute, London, UK.ORCID https://orcid.org/0000-0003-3917-3446

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The benefit of complex 3D models to facilitate the robust testing of new drugs and drug delivery systems during the developmental stages of pharmaceutical manufacturing has recently become distinguished within the field. Recognition of this need by the pharmaceutical industry has provided a motivation for research into the development of reliable complex models for use in drug delivery, biomaterials, and tissue engineering. Both 3D in vitro and ex vivo models can enhance drug-testing and discovery prospects over the more traditionally used 2D, monolayer culture systems and animal models. Despite the widespread acceptance that 3D tissue modelling is advantageous in this field, there remains a lack of standardisation in the models throughout literature. This article provides an extensive review of current literature on in vitro, and ex vivo models of the oral mucosa for drug delivery applications; the advantages, limitations, and recommendations for future development of improved models for this application.

Indexed as

drug discoveryex vivoin vitroOral mucosatissue model

Identifiers

PMID39944725
PMCPMC11815840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.